Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of antiretroviral therapy on HIV-1 viral load in seminal fluid in antiretroviral-naive patients
2014-001348-39Phase 2Active
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of tenofovir disoproxil fumarate, emtricitabine, rilpivirine, elvitegravir, cobicistat and 2 more in Human immunodeficiency virus infection type 1 (3 arms), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Primary endpoints: HIV-1 RNA load in peripheral blood and HIV-1 RNA load in seminal fluid. Started Dec 2014; status: active.
02
Drugs
tenofovir disoproxil fumarateemtricitabinerilpivirineelvitegravircobicistat
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2014-001348-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001348-39.